LARINDA OGAWA: Open Payments
NPI 1669740924 · UNIVERSITY PLACE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$341 in 19 payments from 10 companies in 2025. Trend: 2023 $504 · 2024 $658 · 2025 $341
Food & beverage: $341
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| Amgen Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| UCB, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $37 |
| Organon LLC | 2 | $31 |
| Janssen Biotech, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: OTEZLA, Sotyktu, Bimzelx, COSENTYX, SKYRIZI, VTAMA, TREMFYA, OPZELURA.
Industry payments across WA — which companies pay providers there.
